Fethiann Molecule Applied Co., Ltd.
STRATEGY
Integration in designed and manufactured by Fethiann
Upstream for Biomedicine Patents Products
Midstream for OBM / ODM Applications
Downstream for Markets Demands
Biotechnology Service
Research, development and manufacturing of plant patented raw materials
Fethiann is a Naturals Extraction Solutioner and Healthy Product-designed Provider.
Bio-active Extracts aim at medical indications.
Phytochemistry Research & Synergistic Solution.
Upstream raw material R&D design
Fethiann is an API manufacturer of patented natural herb extracts for bioactive-formula design and biomedical applications, supplying customers with market products as well as OBM and ODM services.
Patented Authorized Raw Material Supplier Ingredient Application Solutions
Providing services for new plant drug development, Medical material manufacturers, food flavor additives, cosmetics application industries.
Providing solutions for rapidly changing indications
Supplying necessities for human life worldwide, health care as medicine and food, and health beauty care as medical material and dressing.
THE MOST feared diseases
“From now on, You can explore the transformative health business programs and strategic partnerships featured on Fethiann’s official website. Achieving your health goals, as well as those of our customers with you together, that is a key importantly of our collaborative approach in the global market.”
Non-Small
Cell Lung Cancer
Non-small cell lung cancer is often detected late, at stage III/IV, which is beyond heartbreaking.
The five-year survival rate is 55%.
It has the highest mortality rate globally, remaining at the top.
Acute Gout
Soreness and Inflammation
Modern diseases and lifestyle habits make the body prone to fatigue, soreness, and inflammation.
Muscle soreness caused by exercise.
Dietary habits lead to the younger onset of acute gout.
So painful that there’s no courage to get out of bed.
Dry Eye Syndrome
The advancement of 3C technology worldwide has significantly increased the prevalence of myopia and dry eye syndrome in children.
One-fourth of ophthalmology patients suffer from dry eye syndrome. The American Academy of Ophthalmology (AAO) estimates that approximately 340 million people globally have dry eye syndrome, including about 20 million in the United States, with the trend continuing to grow.
Medical SkinCare
Medical cosmetic technologies are advancing rapidly, driven by strong market demand, making them a key force in the beauty industry.
Cutting-edge anti-aging products integrate preventive medicine concepts, focusing on delaying the aging process, offering immense market potential.
Obesity
Inflammatory Disease
Dietary habits have led to an increase in obesity-related inflammatory conditions.
The World Obesity Federation (WOF) reports that 2.7 billion people worldwide are obese or overweight.
Global Chronic Disease
Periodontitis
In 2022, the WHO estimated that global cases of periodontitis exceeded 1 billion, primarily due to poor oral hygiene and smoking.
It brings about the prevalence of chronic diseases among the population is as high as approximately 90%, the risk of myocardial infarction and stroke is two to three times higher.
Fethiann Uniquely API Value
The core value of Fethiann lies in the innovative and unique development and application of API (Active Phytochemicals Ingredient ), with a diversified product portfolio. These API components have demonstrated significant efficacy and versatility in clinical studies across multiple indications. Fethiann’s API offerings include FMO® (Superactive Compound of Magnolia figo) and FLC® (Superactive Compound of Litsea cubeba), both protected by multiple international patents. These compounds exhibit exceptional potential in areas such as non-small cell lung cancer (NSCLC) treatment, dental research, eye care, skin repair, and anti-aging applications.
Fethiann’s biomedical research centers on FMO®, a high-efficacy phytochemical active compound extracted from Magnolia figo. This compound has shown remarkable impacts, such as inducing apoptosis in NSCLC cancer cells, contributing to dental research (e.g., whitening and anti-P. gingivalis effects), and supporting skin repair in conditions like atopic dermatitis.
The core value of FMO® is reinforced by its recognition through multiple invention patents granted by the U.S. and Taiwan Intellectual Property Offices, positioning it as a game-changing contributor to the global new drug development supply chain. This technology presents significant medical business opportunities and unlimited potential for application development.
OUR AWARD
Congratulations!
Fethiann has been awarded the Herb Extract Research Innovator of the Year, APAC, in the Biotechnology Awards 2024, making it the first company in Taiwan to receive this honor!
We’re also proud to be featured on the cover of Global Health & Pharma (GHP) news, highlighting Fethiann’s importance in the global health and pharmaceutical industry and showcasing our achievements to the world!
This award recognizes our hard work and success in the field. We’re honored to be leaders in this area.The quality and professionalism of FMO® have been internationally recognized! We’ll keep working hard to contribute more to the health and pharmaceutical fields!
Most Innovative Herb Extract Research Company 2024-APAC International Life Sciences Awards-2024
2019 Taiwan Innotech Expo Invention Contest GOLDEN MEDALS AWARD
